T. Piratvisuth Et Al. , "ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone," 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , vol.40, Massachusetts, United States Of America, 2004
Piratvisuth, T. Et Al. 2004. ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone. 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , (Massachusetts, United States Of America).
Piratvisuth, T., Marcellin, P., Lau, G., Bonino, F., Farci, P., Hadziyannis, S., ... Jin, R.(2004). ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone . 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America
Piratvisuth, T Et Al. "ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone," 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Massachusetts, United States Of America, 2004
Piratvisuth, T Et Al. "ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone." 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , Massachusetts, United States Of America, 2004
Piratvisuth, T. Et Al. (2004) . "ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone." 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) , Massachusetts, United States Of America.
@conferencepaper{conferencepaper, author={T Piratvisuth Et Al. }, title={ALT flares and sustained ALT response in patients with HBeAg-negative chronic hepatitis B treated with peginterferon alfa-2a (40KD) (PEGASYS (R)), peginterferon alfa-2a (40KD) plus lamivudine or lamivudine alone}, congress name={55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)}, city={Massachusetts}, country={United States Of America}, year={2004}}